An improved Pythium insidiosum-vaccine formulation with enhanced immunotherapeutic properties in horses and dogs with pythiosis.

Abstract:

:The immunotherapeutic properties of a new Pythium insidiosum-vaccine formulation (PIV), was evaluated in 18 horses and 6 dogs with proven pythiosis from different enzootic areas in the United States. All injected horses but one responded with a weak (=29 mm, n=3), a mild (30-90 mm, n=7) or a strong (=100 mm, n=7) inflammatory reactions at the site of injection. Three equines with weak or negative reactions at the injection site were not cured. Seven equines with strong reactions at their injection sites, however, were cured. Six of the eight horses with mild reactions were also cured. The remaining two equines responded at first but both relapsed and finally died of their infections. The PIV cured only two of the six dogs used in this study. The new PIV formulation cured 72% of the equines (P=0.048) and 33% of the dogs with pythiosis. Dogs with chronic disease (greater than two months) did not responded to immunotherapy. The finding of eosinophils, mast cells, IgE and precipitin IgG during pythiosis suggested that a T helper 2 (Th2) subset is in place during this disease. In cured horses, the eosinophilic reaction was substituted by lymphocytes and mononuclear macrophages (Th1). This and previous studies strongly support the hypothesis that an immune-modulation from a Th2 to a Th1 subsets may be in part responsible for the PIV's curative properties.

journal_name

Vaccine

journal_title

Vaccine

authors

Mendoza L,Mandy W,Glass R

doi

10.1016/s0264-410x(03)00225-1

subject

Has Abstract

pub_date

2003-06-20 00:00:00

pages

2797-804

issue

21-22

eissn

0264-410X

issn

1873-2518

pii

S0264410X03002251

journal_volume

21

pub_type

杂志文章

相关文献

VACCINE文献大全
  • Development pathway for biodefense vaccines.

    abstract::At the present time it is estimated that the process of development of a vaccine from discovery to licensure takes approximately 18-20 years and costs in excess of US$500 million. For "routine" vaccines, the case for developing a vaccine is straightforward in terms of economics and large scale public health utilizatio...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2009.07.094

    authors: Barrett AD,Beasley DW

    更新日期:2009-11-05 00:00:00

  • Antibiotic resistance in Vibrio cholerae: Understanding the ecology of resistance genes and mechanisms.

    abstract::The unique genetic makeup and remarkable competency of Vibrio cholerae are the key factors that help the cholera pathogen adapt rapidly to adverse environmental conditions and resist the detrimental effect of antimicrobial agents. In the last few decades, V. cholerae that causes acute watery diarrhoeal disease cholera...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2019.06.031

    authors: Das B,Verma J,Kumar P,Ghosh A,Ramamurthy T

    更新日期:2020-02-29 00:00:00

  • Construction and murine immunogenicity of recombinant Bacille Calmette Guérin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin.

    abstract::Three recombinant strains of Mycobacterium bovis Bacille Calmette Guerin (rBCG) were prepared in which the immunogenic B subunit of human Escherichia coli heat labile enterotoxin (LT-Bh) was expressed either as a cytoplasm protein, a cell wall associated lipoprotein or a secreted protein. Intraperitoneal immunisation ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(98)00350-8

    authors: Hayward CM,O'Gaora P,Young DB,Griffin GE,Thole J,Hirst TR,Castello-Branco LR,Lewis DJ

    更新日期:1999-03-05 00:00:00

  • Immunization coverage and timeliness of vaccination in Italian children with chronic diseases.

    abstract::Since children with chronic diseases represent a primary target for immunization strategies, it is important that their immunization coverage and timeliness of vaccines is optimal. We performed a study to measure immunization coverage and timeliness of vaccines in children with type 1 diabetes, HIV infection, Down syn...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2011.02.099

    authors: Pandolfi E,Carloni E,Marino MG,Ciofi degli Atti ML,Gesualdo F,Romano M,Giannattasio A,Guarino A,Carloni R,Borgia P,Volpe E,Perrelli F,Pizzuti R,Tozzi AE

    更新日期:2012-07-20 00:00:00

  • From smallpox eradication to the future of global health: innovations, application and lessons for future eradication and control initiatives.

    abstract::Technological advancements, including landmark innovations in vaccinology through molecular virology, and significant transformation and changes in the society have taken place since the eradication of smallpox thirty years ago. The success with eradicating smallpox gave confidence for initiating the eradication of ot...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2011.09.003

    authors: Tomori O

    更新日期:2011-12-30 00:00:00

  • Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc™).

    abstract::A recombinant ricin vaccine from E. coli (RVEc™), was developed at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) and assessed in an FDA sponsored Phase 1a clinical trial. At the maximum dosage, two of the study participants developed physiological responses that were elevated to the level of...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2020.12.008

    authors: Montgomery VA,Lindsey CY,Smith LA,Webb RP

    更新日期:2021-01-15 00:00:00

  • Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean.

    abstract::The incidence of cervical cancer in Latin America and the Caribbean (LAC) is among the highest in the world. Because there are major demographic shifts happening in LAC countries (population growth, urbanization and ageing) cervical cancer incidence and mortality will likely continue to be a significant public health ...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2008.06.008

    authors: Almonte M,Albero G,Molano M,Carcamo C,García PJ,Pérez G

    更新日期:2008-08-19 00:00:00

  • Do parents prefer inactivated or live attenuated influenza vaccine for their children?

    abstract:OBJECTIVES:To determine the proportion of children whose parents prefer them to receive live, attenuated influenza vaccine (LAIV) or inactivated influenza vaccine (IIV), examine reasons for preferences, and determine what percentage of vaccinated children receive other than the preferred type of vaccine and why. METHO...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2018.10.042

    authors: Santibanez TA,Kahn KE,Bridges CB

    更新日期:2018-11-19 00:00:00

  • Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.

    abstract::Enterotoxigenic Escherichia coli (ETEC), which produces heat labile toxin (LT) and/or heat stable toxin (ST), is considered to be the most common known cause of travellers' diarrhoea (TD). Owing to the antigenic similarity between cholera toxin and LT, immunization with inactivated oral B-subunit/whole-cell cholera va...

    journal_title:Vaccine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.vaccine.2005.05.022

    authors: Leyten EM,Soonawala D,Schultsz C,Herzog C,Ligthelm RJ,Wijnands S,Visser LG

    更新日期:2005-10-17 00:00:00

  • Effect of storage temperatures on opacity and total nitrogen content of cholera vaccine.

    abstract::Fluid cholera vaccine was examined for its stability at 4-8 degrees C, 20-25 degrees C and 37 degrees C with regard to the number of organisms present and the total nitrogen content. Ten batches of fluid cholera vaccine manufactured at the Central Research Institute, Kasauli, India were taken for the study. The number...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/0264-410x(84)90046-x

    authors: Gupta RK,Maheshwari SC,Sharma SB,Ahuja S,Saxena SN

    更新日期:1984-12-01 00:00:00

  • Urticaria following varicella vaccine associated with gelatin allergy.

    abstract::An uncommon reaction to varicella vaccine has been urticaria. Based on two reports of urticaria believed to be due to gelatin in recipients of measles-mumps-rubella vaccine, we suspected gelatin as the cause of generalized urticaria in two children after varicella vaccination. Intradermal testing with gelatin yielded ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(98)00209-6

    authors: Singer S,Johnson CE,Mohr R,Holowecky C

    更新日期:1999-01-28 00:00:00

  • Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.

    abstract::Shigellosis is a major form of bacillary dysentery caused by Shigella infection. Shigella ribosome-based vaccines (SRV), considered among the potent vaccine candidates, are composed of O-antigen and ribosome isolated from S. flexneri 2a. To investigate the immunogenicity and protective efficacy of SRV, mice were vacci...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2007.03.050

    authors: Shim DH,Chang SY,Park SM,Jang H,Carbis R,Czerkinsky C,Uematsu S,Akira S,Kweon MN

    更新日期:2007-06-15 00:00:00

  • Comparison of DNA application methods to reduce BRSV shedding in cattle.

    abstract::We compared the protection afforded by three different DNA application methods against bovine respiratory syncytial virus (BRSV) infection in cattle. A synthetic gene that codes for the G protein of BRSV was inserted into a eukaryotic vector and was used in the vaccine. Intradermal (i.d.) application with a needleless...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(97)00198-9

    authors: Schrijver RS,Langedijk JP,Keil GM,Middel WG,Maris-Veldhuis M,Van Oirschot JT,Rijsewijk FA

    更新日期:1998-01-01 00:00:00

  • Experimental infection by Chlamydia pneumoniae in the hamster.

    abstract::We report that intraperitoneal injection of Chlamydia pneumoniae purified elementary bodies (EBs) in the hamster causes a systemic infection allowing the isolation of viable chlamydiae from several organs for several days post-infection (p.i.). In particular, spleen infection occurred up to Day 7 p.i. in 100% of anima...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2003.09.035

    authors: Sambri V,Donati M,Storni E,Di Leo K,Agnusdei M,Petracca R,Finco O,Grandi G,Ratti G,Cevenini R

    更新日期:2004-03-12 00:00:00

  • Impact of postpartum information about pertussis booster to parents in a university maternity hospital.

    abstract::Parent-to-infant transmission of pertussis remains an issue in France. Although adult booster vaccination was introduced in 2004 as part of a cocooning strategy targeted primarily to parents of young infants, vaccination coverage in this population has remained low. The aim of this study was to evaluate the impact on ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2012.06.071

    authors: Leboucher B,Sentilhes L,Abbou F,Henry E,Grimprel E,Descamps P

    更新日期:2012-08-10 00:00:00

  • Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection.

    abstract::Although largely considered benign, Plasmodium vivax causes disease in nearly 75 million people each year and the available strategies are not sufficient to reduce the burden of disease, therefore pointing to vaccine development as a cost-effective control measure. In this study, the P. vivax merozoite surface protein...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2009.09.046

    authors: Giraldo MA,Arevalo-Pinzon G,Rojas-Caraballo J,Mongui A,Rodriguez R,Patarroyo MA

    更新日期:2009-12-10 00:00:00

  • Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA.

    abstract::Particle-mediated (gene gun) DNA transfer to the epidermis was evaluated for its ability to elicit humoral and cytotoxic T lymphocyte responses using decreasing quantities of plasmid DNA-based antigen expression vectors. Using plasmids encoding human growth hormone, human alpha-1-antitrypsin, and influenza virus nucle...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/0264-410x(95)00069-d

    authors: Pertmer TM,Eisenbraun MD,McCabe D,Prayaga SK,Fuller DH,Haynes JR

    更新日期:1995-01-01 00:00:00

  • Use of a current varicella vaccine as a live polyvalent vaccine vector.

    abstract::Varicella-zoster virus (VZV) is the causative agent of varicella and zoster. The varicella vaccine was developed to control VZV infection in children. The currently available Oka vaccine strain is the only live varicella vaccine approved by the World Health Organization. We previously cloned the complete genome of the...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2014.11.001

    authors: Murakami K,Mori Y

    更新日期:2016-01-04 00:00:00

  • Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro properties.

    abstract::Crystallization of inulin with alum forms a fine (1-2 micron) suspension of electron-dense ovoids; the alum is embedded in inulin particles, which are then converted to the immune stimulant polymorphic form, gamma inulin. This very stable hybrid preparation is termed Algammulin. Preferred conditions for its preparatio...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/0264-410x(91)90063-c

    authors: Cooper PD,Steele EJ

    更新日期:1991-05-01 00:00:00

  • Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus.

    abstract::We constructed double deletion (ΔcydCΔcydD and ΔcydCΔpurD) mutants from virulent Brucella abortus biovar 1 field isolate (BA15) by deleting the genes encoding an ATP-binding cassette-type transporter (cydC and cydD genes) and a phosphoribosylamine-glycine ligase (purD). Both BA15ΔcydCΔcydD and BA15ΔcydCΔpurD double-mu...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2015.11.030

    authors: Truong QL,Cho Y,Park S,Kim K,Hahn TW

    更新日期:2016-01-04 00:00:00

  • Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo.

    abstract::Because recombinant empty viral capsids are potentially attractive vectors for gene therapy, here we examined the ability of human papillomavirus (HPV) virus-like particles (VLPs) to mediate delivery and expression of DNA plasmids in vitro and in vivo. VLP-mediated delivery and expression of a GFP reporter construct i...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2007.01.067

    authors: Malboeuf CM,Simon DA,Lee YE,Lankes HA,Dewhurst S,Frelinger JG,Rose RC

    更新日期:2007-04-30 00:00:00

  • Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013.

    abstract:BACKGROUND:23-Valent pneumococcal polysaccharide vaccine, trade name Pneumovax(®)23 (PPSV23), has been used for decades in the Unites States and has an extensive clinical record. However, limited post-licensure safety assessment has been conducted. OBJECTIVE:To analyze reports submitted to the Vaccine Adverse Event Re...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2016.04.021

    authors: Miller ER,Moro PL,Cano M,Lewis P,Bryant-Genevier M,Shimabukuro TT

    更新日期:2016-05-27 00:00:00

  • Porcine interleukin-3 enhances DNA vaccination against classical swine fever.

    abstract::DNA vectors can be used to deliver vaccine antigens that stimulate effective protective immunity in mice, but in larger, outbred animal species, the protective efficacy is lower or large doses of DNA are required. These data demonstrate that porcine interleukin-3 (IL-3) when delivered to pigs by DNA vector or in low d...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2006.01.023

    authors: Andrew M,Morris K,Coupar B,Sproat K,Oke P,Bruce M,Broadway M,Morrissy C,Strom D

    更新日期:2006-04-12 00:00:00

  • BoLA-DR peptide binding pockets are fundamental for foot-and-mouth disease virus vaccine design in cattle.

    abstract::This large study investigates the associations between bovine major histocompatibility complex DRB3 alleles and their binding pockets with the immune response to a 40-mer peptide derived from foot-and-mouth disease virus (FMDV) VP1. A crossbred (Charolais and Holstein) cattle population (n=197) was immunised with the ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2009.09.131

    authors: Baxter R,Craigmile SC,Haley C,Douglas AJ,Williams JL,Glass EJ

    更新日期:2009-12-10 00:00:00

  • Strategy for the control of hepatitis B virus infection in the Middle East and North Africa. The Middle East Regional Study Group.

    abstract::Hepatitis B virus (HBV) infection and HBV-associated diseases are prevalent in many parts of the Middle East and North Africa. Postnatal horizontal childhood transmission appears to be the predominant method by which high hepatitis B carrier rates are maintained. To control hepatitis B in this region, mass immunizatio...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:

    authors: Toukan A

    更新日期:1990-03-01 00:00:00

  • Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.

    abstract::General vaccination with the 7-valent pneumococcal conjugate vaccine was recommended in Germany in July 2006 for all children <2 years. The proportion of reported invasive pneumococcal disease (IPD) caused by vaccine serotypes before vaccine introduction was considerably lower than in the US. We report data from natio...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2009.04.057

    authors: Rückinger S,van der Linden M,Reinert RR,von Kries R,Burckhardt F,Siedler A

    更新日期:2009-06-24 00:00:00

  • Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?

    abstract::Outer membrane protein (OMP) vaccines are being developed against Neisseria meningitidis serogroup B which may provide protection against common circulating serotypes and serosubtypes in some countries. However, limited data is available in Europe from genosubtyping meningococci. We therefore undertook a retrospective...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(03)00033-1

    authors: Clarke SC,Diggle MA,Mölling P,Unemo M,Olcén P

    更新日期:2003-06-02 00:00:00

  • Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines.

    abstract::A number of challenges for developing a protective pre-pandemic influenza A vaccine exists including predicting the target influenza strain and designing the vaccine for an immunologically naïve population. Manufacturing and supply of the vaccine would also require implementing ways to increase coverage for the larges...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2017.07.107

    authors: Allen JD,Owino SO,Carter DM,Crevar CJ,Reese VA,Fox CB,Coler RN,Reed SG,Baldwin SL,Ross TM

    更新日期:2017-09-12 00:00:00

  • Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field.

    abstract::From 1983 to 1993 two anti-hepatitis B vaccinal strategies were adopted in two small towns of Southern Italy at high incidence for HBV infections: Afragola (prevalence of HBsAg carriers of 13.4%) and Frattamaggiore (prevalence of HBsAg carriers of 12.9%). In Afragola, the universal vaccination of infants in their firs...

    journal_title:Vaccine

    pub_type: 临床试验,杂志文章

    doi:10.1016/0264-410x(95)00056-7

    authors: Da Villa G,Picciottoc L,Elia S,Peluso F,Montanaro F,Maisto T

    更新日期:1995-09-01 00:00:00

  • Knowledge and attitudes towards influenza vaccination of health care workers in emergency services.

    abstract::Annual vaccination rates among French health care workers (HCWs) are in decline even in Emergency Services to which patients at highest risk of influenza complications are admitted, and in which HCWs have the greatest risk of exposure to influenza from patients. We aimed here to identify knowledge and attitudes toward...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2016.11.086

    authors: Hulo S,Nuvoli A,Sobaszek A,Salembier-Trichard A

    更新日期:2017-01-05 00:00:00